Brief: Solid Biosciences Appoints Kevin Tan, Cfa, As Chief Financial Officer
09/01/2023 13:43
Solid Biosciences Inc SLDB.O :
* SOLID BIOSCIENCES APPOINTS KEVIN TAN, CFA, AS CHIEF
FINANCIAL
OFFICER
Source text for Eikon: ID:nGNX2b2qBt
Further company coverage: SLDB.O
Recent news on Solid Biosciences
See all newsSolid Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Solid Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Solid Biosciences Q2 net loss widens on higher R&D costs
Marketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs